Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD
Authors:
Open Access
Abstract
Objective: To describe the changes in prescribing of oral anticoagulant (AC) and antiplatelet (AP) agents in patients with non-valvular atrial fibrillation (NVAF) in the UK and to identify the characteristics associated with deviation from guideline-based recommendations. Design: Five cross-sectional analyses in a large retrospective population-based cohort study. Setting: General practices contributing data to the UK Clinical Practice Research Datalink. Participants: The study included patients with a diagnosis of NVAF and eligible for anticoagulation (CHA 2 DS 2 -VASc score ≥2) on 1 April of 2012, 2013, 2014, 2015 and 1st January 2016. Results: The proportion of patients being treated with AC increased at each index date, showing an absolute rise of 16.7% over the study period. At the same time, the proportion of patients treated with an AP alone was reduced by half, showing an absolute decrease of 16.8%. The proportion of patients not receiving any antithrombotic (AT) treatment remained the same across the study period. A number of predictors were identified for AP alone or no treatment compared with AC treatment. Conclusion: Major improvements in the AT management of patients with NVAF for stroke prevention in the UK were observed between April 2012 and January 2016. Despite this, nearly 20% of at-risk patients still received AP alone and over 15% were on no AT agents in January 2016.Keywords
Funding Information
- Bristol-Myers Squibb
This publication has 39 references indexed in Scilit:
- Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillationHeart, 2016
- Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AFEuropean Heart Journal, 2016
- Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009Heart, 2012
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEP Europace, 2012
- A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practiceJournal of Thrombosis and Haemostasis, 2010
- Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial FibrillationEuropean Heart Journal, 2006
- Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate AnticoagulationJACC, 2005
- Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary CareStroke, 2005
- Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research databaseHeart, 2001
- Stroke Severity in Atrial FibrillationStroke, 1996